Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Immunoglobulin G hypogammaglobulinemia was found in 44.7% of patients with acute exacerbations of COPD receiving triple ...

belief that Ohtuvayre's bronchodilator and non-steroidal anti-inflammatory activity can re-define the COPD treatment paradigm." The encouraging sales figures come at a time when treatment options ...

targeting moiety via a linker reported to be useful for the treatment of cancer, rheumatoid arthritis, renal disorders, multiple sclerosis, alopecia areata, urticaria, psoriasis and chronic ...

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Overall rates of colorectal cancer diagnoses and deaths have dropped in recent decades, likely due to changes in risk factors, improved screening, and improved treatment. Most of those ...

If you tested negative for all STIs, you don’t need treatment but continue to use barrier methods during any sexual activity. If you tested positive for one (or more) STIs Some STIs are curable ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

“This caused an episode of vomiting which led to him inhaling some and a sudden worsening of his respiratory condition" Earlier in the day, Friday, Pope received the Eucharist.

hGraduate Program in Stem Cell and Regenerative Medicine, Stanford University, Stanford, CA, USA ...